Results 121 to 130 of about 1,335 (167)
Role of Perinatal Stem Cell Secretome as Potential Therapy for Muscular Dystrophies. [PDF]
BiomedicinesPacilio S +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Congenital muscular dystrophy with partial deficiency of merosin
Journal of the Neurological Sciences, 1997We present a Japanese patient who has congenital muscular dystrophy, with partial merosin deficiency. The patient had characteristic findings of clinical features and brain MRI. Muscle biopsy showed advanced muscular dystrophy, with greatly reduced muscle fibers and massive infiltration of interstitial connective and fatty tissues.
Nobutada Tachi +2 more
exaly +3 more sources
Severe classical congenital muscular dystrophy and merosin expression
Clinical Genetics, 1998Vajsar J, Chitayat D, Becker LE, Ho M, Ben‐Zeev B, Jay V. Severe classical congenital muscular dystrophy and merosin expression. Clin Genet 1998: 54: 193–198. 0 Munksgaard, 1998It has been suggested that patients with autosomal recessive merosin deficient congenital muscular dystrophy (CMD), as opposed to the merosin positive cases form a homogeneous ...
David Chitayat, L E Becker
exaly +3 more sources
Prenatal Detection of Merosin Expression in Human Placenta
Neuropediatrics, 1994F M Tome, M Fardeau
exaly +3 more sources
Merosin and congenital muscular dystrophy
Microscopy Research and Technique, 2000Merosin (also called as Laminin-2) is an isoform of laminin comprised of the alpha2, beta1 and gamma1 chains. In European populations, half of the patients with classical congenital muscular dystrophy have mutations of the LAMA2 gene (6q22-23) and present reduced or absence of laminin alpha2 chain.
Y, Miyagoe-Suzuki +2 more
openaire +2 more sources
Pediatric and Developmental Pathology, 2000
The clinical features of merosin-positive congenital muscular dystrophy (CMD) and merosin-deficient CMD are well known, with those of merosin-deficient CMD being more severe. Whether the severity of histopathological findings correlates with these clinical features remains unanswered.
B, Talim +6 more
openaire +2 more sources
The clinical features of merosin-positive congenital muscular dystrophy (CMD) and merosin-deficient CMD are well known, with those of merosin-deficient CMD being more severe. Whether the severity of histopathological findings correlates with these clinical features remains unanswered.
B, Talim +6 more
openaire +2 more sources
Pediatric Neurology, 1998
This study evaluates whether abnormalities of visual function are present in children with congenital muscular dystrophy and whether these, if present, are associated with merosin status or magnetic resonance imaging (MRI) findings. Twenty children (age range 5-17 years) with a diagnosis of classical congenital muscular dystrophy were assessed on ...
E, Mercuri +5 more
openaire +2 more sources
This study evaluates whether abnormalities of visual function are present in children with congenital muscular dystrophy and whether these, if present, are associated with merosin status or magnetic resonance imaging (MRI) findings. Twenty children (age range 5-17 years) with a diagnosis of classical congenital muscular dystrophy were assessed on ...
E, Mercuri +5 more
openaire +2 more sources
Merosin/laminin-2 and muscular dystrophy
Neuromuscular Disorders, 1996The laminins are a family of structural basement membrane components with major influences on cells. They are high molecular weight glycoproteins composed of three different but homologous chains, alpha, beta and gamma. At present 10 different chains have been identified.
Wewer, U M, Engvall, E
openaire +2 more sources